Back to Search
JESSICA ASHFORD, PHARMD
PHARMD
Pharmacist
NPI: 1992009195Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RP444799(PA)
Research & Publications (20)
Prenatal smoking and internalizing and externalizing problems in children studied from childhood to late adolescence.
PMID 18520960·J Am Acad Child Adolesc Psychiatry·2008
8-other
Early risk indicators of internalizing problems in late childhood: a 9-year longitudinal study.
PMID 18341546·J Child Psychol Psychiatry·2008
8-other
Integration of EEG and brain imaging: advancing the understanding of neuro-cognitive dysfunction.
PMID 18997290·J Alzheimers Dis·2008
8-other
Should older adults be screened for dementia? It is important to screen for evidence of dementia!
PMID 19595920·Alzheimers Dement·2007
8-other
What is aging? What is its role in Alzheimer's disease? What can we do about it?
PMID 16006669·J Alzheimers Dis·2005
7-preclinical
APOE genotype effects on Alzheimer's disease onset and epidemiology.
PMID 15181244·J Mol Neurosci·2004
6-review
Non-familial Alzheimer's disease is mainly due to genetic factors.
PMID 12226536·J Alzheimers Dis·2002
8-other
Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease.
PMID 10647605·J Nucl Med·2000
8-other
Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots.
PMID 18760504·Neurobiol Aging·2010
8-other
Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.
PMID 19465537·J Pediatr Psychol·2010
2-rct
Central obesity and increased risk of dementia more than three decades later.
PMID 19297682·Neurology·2009
8-other
Evidence-based systematic review: Oropharyngeal dysphagia behavioral treatments. Part V--applications for clinicians and researchers.
PMID 19533535·J Rehabil Res Dev·2009
1-meta
Evidence-based systematic review: Oropharyngeal dysphagia behavioral treatments. Part IV--impact of dysphagia treatment on individuals' postcancer treatments.
PMID 19533534·J Rehabil Res Dev·2009
1-meta
Evidence-based systematic review: Oropharyngeal dysphagia behavioral treatments. Part III--impact of dysphagia treatments on populations with neurological disorders.
PMID 19533533·J Rehabil Res Dev·2009
1-meta
Evidence-based systematic review: Oropharyngeal dysphagia behavioral treatments. Part II--impact of dysphagia treatment on normal swallow function.
PMID 19533532·J Rehabil Res Dev·2009
1-meta
Evidence-based systematic review: Oropharyngeal dysphagia behavioral treatments. Part I--background and methodology.
PMID 19533531·J Rehabil Res Dev·2009
1-meta
Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells.
PMID 19429119·Neurosci Lett·2009
8-other
Leptin: a novel therapeutic strategy for Alzheimer's disease.
PMID 19387109·J Alzheimers Dis·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 26 DALLAS VILLAGE SHOPPING CTR
DALLAS, PA 18612 - Phone
- (570) 674-5577
Quick Facts
- NPI
- 1992009195
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile